• SENSEX 76,567.95
    -187.10 (--0.24%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • HDFC Bank
    744.50 726.75(%)
  • Bluestone Jewel
    742.30 400.40(%)
  • Bharti Airtel
    1,931.00 1,745.00(%)
  • Oracle Fin.Serv.
    9,950.00 6,232.20(%)
  • Tanla Platforms
    656.70 765.75(%)
  • Gandhar Oil Ref.
    283.85 245.00(%)
  • IndusInd Bank
    1,002.50 710.85(%)
  • United Spirits
    1,435.00 1,489.00(%)
  • Eternal
    296.15 368.40(%)
  • Adani Green
    1,392.35 767.00(%)
  • SBI Funds Mgt.
    597.30 625.00(%)
  • HEG
    675.90 685.10(%)
  • Kalyan Jewellers
    588.60 327.15(%)
  • Dhabriya Poly.
    472.00 490.00(%)
  • Maruti Suzuki
    13,579.85 17,371.60(%)
  • SRF
    2,700.00 2,313.75(%)
  • Bandhan Bank
    169.50 134.30(%)
  • Reliance Industries
    1,277.85 1,253.65(%)
  • NTPC Green Ene.
    99.59 119.93(%)
  • Bajaj Auto
    11,320.00 11,025.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Strides Pharma Science Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 16996.0
  • ISIN : INE939A01011
1,040.70 -11 (-1.01%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    1,000.90

  • Today’s High

    1,052.00

  • Open

    1,052.00

  • Perv Close

    1,051.30

  • 52W Low

    768.65

  • 52W High

    1,231.00

Key Indicators

  • P/E(TTM)

    52.23

  • Mar.Cap (₹Cr.)

    9,592.41

  • Div & Yield %

    0.48

  • Book Value(₹)

    356.24

  • Debt-Equity Ratio

    -1.01

  • AGM Date

    22-Jul-2026

  • EPS

    19.92

  • P/E Ratio

    52.23

Financials Ratios

  • Debt-Equity Ratio

    1.28

  • Mar.Cap (₹Cr.)

    9,592.41

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    92.17

  • BV (₹)

    356.20

  • Sales( ₹ in Cr.)

    2,180.14

  • NP (in Cr.)

    183.64

  • NP Var(%)

    -94.0

  • Div%

    50.0

  • CPS (₹)

    29.80

  • EPS (₹)

    19.90

  • Traded Value (₹ in Lakhs)

    9,590.57

  • 52 Week High

    1,231.00

  • 52 Week Low

    768.65

  • Price BSE

    1041.0

  • Price NSE

    1,041.00

  • Market Capital( in Cr.)

    9,590.57

  • P/C Ratio

    34.90

  • P/E Ratio

    52.30

  • Price Vs.BV

    19.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57 1,691.93
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,139.42 1,866.12 1,854.50 1,979.00 1,857.57 1,691.93
Other Income 2,873.24 127.54 84.07 123.49 117.09 93.07
Stock Adjustments 27.20 -14.87 -21.04 -114.26 117.53 2.88
Total Income 5,039.86 1,978.79 1,917.53 1,988.23 2,092.19 1,787.88
EXPENDITURE :            
Raw Materials 1,110.74 954.29 1,044.57 987.26 1,106.41 894.84
Power and Fuel Cost 36.00 47.90 45.54 43.76 45.82 44.53
Employee Cost 377.59 348.92 267.01 272.09 272.72 230.23
Other Manufacturing Expenses 132.85 143.04 130.03 151.87 134.86 117.43
Selling and Administration Expenses 246.18 192.14 182.64 260.83 171.51 117.95
Miscellaneous Expenses 0.85 19.83 80.19 72.31 84.56 85.37
Employee Benefit Expenses 377.59 348.92 267.01 272.09 272.72 230.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,904.21 1,706.11 1,749.98 1,788.12 1,815.87 1,490.35
Operating Profit 3,135.66 272.68 167.54 200.11 276.32 297.53
Interest 145.91 139.38 138.68 74.24 65.34 66.84
Gross Profit 2,989.75 133.30 28.86 125.87 210.98 230.69
Depreciation 84.61 87.41 93.62 104.37 99.34 94.24
Profit Before Tax 2,905.14 45.89 -64.76 21.50 111.64 136.45
Current Tax -1.46 -0.12 -49.84 -169.66 33.65 18.76
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 20.39 1.46 -19.60 10.98 -0.26 -2.59
Reported Net Profit 2,886.21 44.55 4.68 180.19 78.24 120.28
Extraordinary Items -0.12 -5.53 -16.32 4.23 3.26 3.41
Adjusted Net Profit 2,886.33 50.08 21.00 175.96 74.98 116.87
Adjustment below Net Profit -2,827.06 -57.19 0.00 0.00 0.00 -57.25
P & L Balance brought forward 719.38 745.57 740.89 583.13 522.80 616.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 22.99 13.55 0.00 22.43 17.91 156.30
P & L Balance carried down 755.55 719.38 745.57 740.89 583.13 522.80
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 25.00 15.00 0.00 25.00 140.00
Dividend Per Share(Rs) 4.00 2.50 1.50 0.00 2.50 14.00
Earnings Per Share-Unit Curr 313.16 4.85 0.52 20.07 8.72 13.43
Earnings Per Share(Adj)-Unit Curr 313.16 2.13 0.23 8.79 3.82 5.88
Book Value 346.42 383.84 380.71 379.36 362.18 352.68
Book Value(Adj)-Unit Curr 346.42 168.20 166.83 166.24 158.71 154.54

Shareholding Pattern

  • Promoter Group

    27.91%

  • Public Share Holding

    72.09%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 734 0.00 734 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,908,899 4.24 3,908,899 10
Partnership Firms-Indian (Promoter & Group) 21,309,635 23.12 21,309,635 2
Persons Acting in Concert 0 0.00 0 0
Trusts 510,000 0.55 510,000 2
Others 0 0.00 0 0
Sub Total 25,729,268 27.91 25,729,268 15
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 8,125 0.01 8,125 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9,025 0.01 7,999 7
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 26,171,427 28.39 26,171,427 229
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,595,627 4.99 4,595,627 4
Mutual Funds / UTI 8,043,509 8.73 8,043,509 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,553,596 1.69 1,553,596 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 40,381,309 43.81 40,380,283 262
2] Non Institution
Bodies Corporate 3,498,894 3.80 3,497,776 863
Clearing Members 689 0.00 689 3
Directors of their Relatives 110,946 0.12 110,946 9
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,941,186 2.11 1,939,879 1,173
Foreign Non Institution Other 21,000 0.02 21,000 1
Hindu Undivided Families 1,159,881 1.26 1,159,881 1,807
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,941,660 7.53 6,941,660 89
Individuals holding nominal share capital up to Rs. 1 lakh 11,882,223 12.89 11,826,346 89,337
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,065 0.00 1,065 6
Others 504,593 0.55 504,593 1,291
Sub Total 26,062,137 28.28 26,003,835 94,579
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 92,172,714 100.00 92,113,386 94,856

Company Background

Strides Pharma Science LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Strides Pharma Science Ltd
  • BSE Code : 16996.0
  • ISIN : INE939A01011

  • Incorporation Year

    1990

  • Registered Office

    No 201 Devavrata Sector 17
    Vashi, Navi Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924/27893199

  • FAX

    91-22-27892942

  • Chairman

    Arun Kumar

  • Managing Director

    Badree Komandur

  • Company Secretary

    Manjula Ramamurthy

  • Auditor

    BSR & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Strides Pharma Science Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Strides Pharma 1,040.50 2,185.61 2,139.42 52.23 4.62
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
J B Chemicals & 2,412.25 3,945.17 3,889.89 57.46 24.24
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77